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SUMMARY
Somatic hypermutation of immunoglobulin variable region genes occurs within germinal centres
(GCs) and is the process responsible for affinity maturation of antibodies during an immune
response. Previous studies have focused almost exclusively on the immune response to haptens,
which may be unrepresentative of epitopes on protein antigens. In this study, we have exploited a
model system that uses transgenic B and CD4þ T cells specific for hen egg lysozyme (HEL) and a
chicken ovalbumin peptide, respectively, to investigate a tightly synchronized immune response to
protein antigens of widely differing affinities, thus allowing us to track many facets of the
development of an antibody response at the antigen-specific B cell level in an integrated system
in vivo. Somatic hypermutation of immunoglobulin variable genes was analysed in clones of
transgenic B cells proliferating in individual GCs in response to HEL or the cross-reactive low-
affinity antigen, duck egg lysozyme (DEL). Molecular modelling of the antibody–antigen interface
demonstrates that recurring mutations in the antigen-binding site, selected in GCs, enhance
interactions of the antibody with DEL. The effects of these mutations on affinity maturation
are demonstrated by a shift of transgenic serum antibodies towards higher affinity for DEL in DEL-
cOVA immunized mice. The results show that B cells with high affinity antigen receptors can revise
their specificity by somatic hypermutation and antigen selection in response to a low-affinity, cross-
reactive antigen. These observations shed further light on the nature of the immune response to
pathogens and autoimmunity and demonstrate the utility of this novel model for studies of the
mechanisms of somatic hypermutation.
INTRODUCTION
Following antigen challenge, antigen-specific B cells enhance
the ‘quality’, i.e. specificity and affinity, of the antibodies they
produce over time. This process is important for protective
immunity to pathogens and defects in this process lead to a
profound susceptibility to bacterial infections.1,2
This improvement in antibody affinity and specificity takes
place in the microenvironment of the germinal centre (GC) by
the process of affinity maturation of B cell antigen receptors.3–5
First, rearranged immunoglobulin (Ig) variable (V) region genes
are mutated randomly in centroblasts within the dark zone of the
GC by a process known as somatic hypermutation.6–9 Surface
expression of these mutated Igs is up-regulated during differ-
entiation of the centroblasts to centrocytes, which migrate to the
light zone. Here they are preprogrammed to die by apoptosis
unless they receive survival signals by ligation of the B cell
receptor (BCR) with antigen which they encounter on the
surface of follicular dendritic cells (FDCs). Competition for
antigen results in selection of B cells with high affinity recep-
tors. The surviving B cells receive further signals from CD4þ
helper T cells via their CD40 ligand and differentiate into either
long-lived memory cells or antibody-producing plasma
cells.3,10
Basic features of the hypermutation process have been
deduced from the sequences of antibodies recovered from
different stages of immune responses to a variety of antigens
and haptens.11 Single nucleotide substitutions are introduced in
a stepwise manner into the Ig V region genes at an estimated rate
of one mutation per 1000 base pairs (bp) per generation.6
Mutations occur in both DNA strands12 with a strong bias
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for transitions over transversions8 and the mutation machinery
targets particular sequence motifs, or ‘hot spots’ of which the
RGYW motif is best known.13–15
Somatic hypermutation in GCs has been studied primarily in
mice responding to haptens, in which the response is dominated
by single rearranged heavy and light chain V-genes.16–18 It has
been difficult to examine the germinal centre response to protein
antigens directly in vivo due to the low precursor frequency and
heterogeneity of B cells specific for a particular protein and the
presence of multiple epitopes on the antigen, resulting in a
response comprising a very heterogeneous population of rear-
ranged V-genes.19 In this study, we have exploited an adoptive
transfer mouse model20 which uses antigen receptor transgenic
(Tg) B and CD4þ T cells specific for hen egg lysozyme (HEL)
and a chicken ovalbumin (cOVA) peptide, respectively, to
investigate a tightly synchronized immune response to a protein
antigen. Increasing the precursor frequency of T and B lym-
phocytes to defined epitopes in this model has greatly facilitated
studies on B cell differentiation and migration into the lymphoid
follicle,20,21 receptor-editing of anergic B cells22 and self/non-
self B cell discrimination.23,24
The MD4 mouse strain23 carries rearranged heavy and light
chain transgenes which encode the HEL-specific monoclonal
antibody, HyHEL-10, offering a unique opportunity to study B
cell somatic hypermutation in germinal centres during the
immune response to a protein antigen in vivo. We have exploited
the fact that the HyHEL-10 antibody has approximately 3000
times lower affinity for duck egg lysozyme [Ka ¼ 13  107
M
1 (25)] compared to HEL (Ka ¼ 4. 5  1010 M1) but the
MD4 Tg B cells are still able to expand in response to this lower-
affinity antigen.26
The availability of the high resolution 3-D structures of
HyHEL-10, its antigen and the antibody–antigen complex27–29
has allowed us to use molecular modelling to study the effects of
mutations in B cell clones proliferating within developing GCs.
Molecular modelling of the HyHEL-10/DEL interface indicates
that antigenic selection for mutations that enhance interactions
with DEL specific residues is taking place within the GCs of
DEL-cOVA immunized recipients. Selection of these mutations
was accompanied by increased affinity of the transgenic anti-
bodies for DEL.
To our knowledge, this is the first time that selection of
replacement mutations in GC B cells responding to a protein
antigen has been observed directly in vivo and their effects on
the affinity of the antibody–antigen interaction followed
through high resolution modelling of the receptor–antigen
complex. This study expands our understanding of the indivi-
dual and cumulative effects of somatic hypermutation on the
binding of antibody to its epitope, leading to further insight into
how the immune system combats infectious diseases by refine-
ment of the antibody–antigen interaction during the evolution of
the immune response.
METHODS AND MATERIALS
Preparation of DEL-cOVA and HEL-cOVA conjugates
Lysozyme was prepared from domestic duck eggs following the
method described previously by Smith-Gill et al.30 It was free of
contaminants, as determined by SDS-PAGE, and was shown to
contain high specific activity by the Micrococcus lysodeikticus
cell turbidimetric assay.31
Duck egg lysozyme or hen egg lysozyme (Biozyme Labora-
tories, Gwent, UK) was coupled to chicken ovalbumin (Sigma,
Poole, UK) using glutaraldehyde (Sigma).20
Mouse strains, adoptive transfer and immunization
D01110 (BALB/c  C57BL/6) F1 and MD4 (BALB/
c  C57BL/6) F1 transgenic (Tg) mice were used. All mice
were bred and maintained in a specific pathogen-free facility at
the University of Glasgow following home office regulations.
D01110 T cells express a Tg TCR specific for chicken oval-
bumin peptide (323–329) in the context of 1-Ad.32 Cell suspen-
sions containing 1–25  106 D01110 CD4þ T cells and 25–
5  106 MD4 B cells were transferred intravenously into
(BALB/c-Ighb  C57BL/6)F1 recipients.20 After 1 day, HEL-
cOVA or DEL-cOVA conjugate (130 mg) in complete Freund’s
adjuvant (CFA) was injected subcutaneously on the back. The
Tg TCR was detected by the clonotypic monoclonal antibody
KJ1-26.33 MD4 B cells express the anti-HEL HyHEL-10 mono-
clonal antibody with both IgM and IgD isotypes23 and can be
identified using an antibody specific for the IgMa allotype. The
percentage of CD4þ KJ1-26þ D01110 T cells and B220þ
IgMaþ MD4 B cells from the transgenic donors was determined
by flow cytometry.
Immunohistochemistry/FACS
The lymph nodes (brachial, axillary, cervical, inguinal and para-
aortic) were harvested at specific time-points; half the lymph
nodes from each recipient were used to prepare single cell
suspensions and stained for flow cytometry as previously indi-
cated.20 FACS data were collected and analysed using FACS-
calibur (Becton Dickinson, Oxford, UK) and the Cellquest
software program, respectively.
The remaining lymph nodes were frozen in liquid nitrogen in
OCT embedding medium (Miles, Elkurt, IN, USA) and stored at
808. Tissue sections (6 mM) were mounted on precoated slides
(Speci-Microsystems, Surrey, UK), fixed in acetone and stained
with biotinylated anti-IgMa, HEL, DEL, peanut agglutinin
(PNA) and anti-Thy12 as described previously.20
Competitive ELISA
All reagents were diluted in ED buffer (02% fetal calf serum,
005% Tween 20 in PBS) unless stated otherwise. Sera from
recipients were diluted and mixed with various quantities of hen
egg lysozyme (1 mg/ml5 pg/ml) or duck egg lysozyme
(0125 mg/ml01 mg/ml) and incubated at 48 overnight. The
titre of free anti-IgMa serum antibodies in solution was assayed
by ELISA on plates (Immulon-4) coated with either 20 mg/ml
DEL or HEL diluted in PBS. Detection was achieved using
biotinylated anti-mouse IgMa (PharMingen, Oxford, UK) fol-
lowed by extravidin peroxidase conjugate (Sigma).
Microdissection, PCR amplification and cloning of the
HyHEL-10 light and heavy chain V transgenes
Germinal centres stained with the anti-allotype antibody IgMa
and PNA (Vector, Burlingame, CA, USA) were excised by micro-
dissection under Scott’s tapwater substitute (035% NaHCO3,
Analysis of B cell response to a protein antigen 275
# 2003 Blackwell Publishing Ltd, Immunology, 108, 274–287
02% MgS04) using a Nikon Narishige micromanipulator.
Photographs were taken with a Nikon Diaphot inverted micro-
scope and a CCD camera. The tissue was digested in 30 ml of
proteinase K (143 mg/ml; Boehringer Mannhiem) for 1 hr at
508 followed by heat-inactivation at 958 for 10 min.
The HyHEL-10 heavy and light V(D)J transgenes were
amplified by two rounds of polymerase chain reaction (PCR)
using ExpandTM DNA polymerase (Boehringer Mannheim,
Indianapdis, IN, USA) and nested oligonucleotide primers
(Table 1). To avoid contamination of reagents with amplified
Ig V genes, all procedures before PCR took place in a separate
laboratory from that where PCR amplification and all subse-
quent DNA manipulations were performed.
HyHEL-10 Vk and VH genes contain 2 and 13 nucleotide
differences from the closest germline genes, Vk23–43 and
VH36-60, respectively.34 The anti-lysozyme HyHEL-10 Ig
heavy (H) chain gene construct consists of the LVDJH gene
segment, m-switch and constant regions, m-membrane exons, the
d-constant, secretory and membrane gene segments. The anti-
lysozyme HyHEL-10 Ig light (L) chain gene construct com-
prises the LVJk gene segment and the k-constant region. Both
transgene constructs have been described in detail previously.23
External 50 oligonucleotides (LL/LH) hybridized to relatively
conserved motifs within the immunoglobulin signal sequences
of the VH3 or Vk23 gene families.35 The external 30 oligonu-
cleotides (IH/IL) were specific for the intronic sequences
immediately downstream from the JH336 or Jk237 gene seg-
ments. Internal oligonucleotides (VL/JL, VH/JH) were com-
plementary to the 50 or 30 ends of the rearranged HyHEL10 light
and heavy chain V regions, respectively.34,38
The HyHEL-10 light chain V-gene was amplified using the
external oligonucleotides LL and IL followed by internal
primers VL and JL. The HyHEL-10 heavy chain V-gene seg-
ment was amplified with external oligonucleotides LH and IH
followed by internal primers VH and JH.
The cycling parameters for the PCRs were: 958, 2 min; (948,
1 min, 558, 1 min, 728, 2 min)  40; 728, 15 min except that
the annealing temperature was 528 for the primary amplification
of the HyHEL-10 light chain V-gene. A wax-gem (Perkin-
Elmer, Norwalh, CT, USA) facilitated hot start was used in
all PCRs.
Ten microlitres of the digested tissue was used in all primary
amplification PCRs and 2 ml of the primary PCR product was
used in the second amplification step. Negative control samples
containing water instead of DNA were always amplified in
parallel with the DNA from the digested tissue. PCR products
were purified using either a Qiaquick gel extraction kit or a PCR
purification kit (Qiagen, Sussex, UK), ligated into plasmid
vector pCR2 and cloned using the TA cloning system (Invitro-
gen, Paisley, UK).
Sequencing and analysis of the HyHEL-10 light and heavy
chain V region transgenes
Plasmid DNA was isolated from single clones and positive
transformants were chosen at random for automated DNA
sequencing (DNASHEF, Edinburgh, UK). Sequence chromato-
graphs were analysed with Editview and alignments were
carried out by DNAplot. The MD4 B cells contain four copies
of the transgene; one copy contains a silent mutation at amino
acid position 45 of the Vk region39 and was eliminated from any
mutational analysis. Dendrograms were produced using seq-
uences with shared subsets of somatic mutations cloned from
individual germinal centres; each unique sequence represents
the B cell expressing that mutated V-gene.
RESULTS
Kinetics of the DEL-cOVA response
To ensure that DEL coupled to cOVA can elicit B cell help from
TCR Tg T cells, as reported previously for HEL, we examined
the clonal expansion of Tg T and B cells. HEL-specific Tg B
cells and OVA-specific TCR T cells were transferred into naive
congenic (BALB/c-Ighb  C57BL/6) F1 mice, which were then
immunized with either HEL-cOVA or DEL-cOVA in CFA. The
lymph nodes were removed from the recipients at days 3, 5, 7, 9
and 14 after immunization, and cells from half the lymph nodes
were analysed by flow cytometry. The remaining lymph nodes
were used for immunohistochemical analysis. Clonal expansion
of both the Tg D01110 T and MD4 B cells in response to the
lower-affinity conjugate, DEL-cOVA, was detected in vivo. As
shown in our previous studies20,21 the peaks of clonal expansion
in response to the high-affinity HEL-cOVA conjugate were
observed on days 3 and 5 for the Tg T and B cells, respectively
(Fig. 1). In contrast, following immunization with DEL-cOVA,
the expansion of Tg OVA-specific T cells was slower than
observed in response to the higher affinity, HEL-cOVA. This
suggests that B cells present DEL-acquired cOVA less effi-
ciently to T cells at the earlier stages of GC formation due to
their lower affinity for DEL-cOVA40 or, alternatively, that
the two antigens are presented by phenotypically distinct anti-
gen-presenting cells. There was no significant delay in the B
cell response to DEL-cOVA compared to HEL-cOVA. This
observation is in agreement with a recent finding that high-
and low-affinity B cells have the same intrinsic capacity to
respond to antigen.41 These results demonstrate that the MD4 B
cells respond to DEL while receiving help from the D01110 T
cells.
Localization of Tg MD4 B cells and D01110 T cells during
the DEL-cOVA response
Following immunization, antigen-specific T cells undergo clo-
nal expansion and migrate into B cell follicles, where they
Table 1. Oligonucleotide primers
Oligonucleotide
name Sequence (50-30)
LL TGGAYTYCAGCCTCCAGA
IL TAACACCTGATCTGAGAATG
VL GATATTGTGCTAACTCAGTCTCC
JL TTATTTCCAGCTTGGTCCC
LH TGTTGACAGYCVTTCCKGGT
IH GTTGAATCTTGATTCCCGTT
VH GTGCAGCTTCAGGAGTCAGGA
JH TGCAGAGACAGTGACCAGAGT
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provide help to B cells.20,21 Similar follicular migration for both
the Tg B and T cells was displayed in both the DEL-cOVA and
HEL-cOVA immunized recipients. PNA-positive GCs contain-
ing transgenic IgMaþ B cells were observed at days 5–14 with
both the high (HEL)- and low (DEL)-affinity antigens by
immunohistochemistry (Fig. 2) and three-colour flow cytome-
try (unpublished data). Although numerous anti-HEL-specific
Tg B cells were detected (Fig. 2a,b) within the GCs of both
HEL-cOVA and DEL-cOVA immunized mice, no DEL-binding
B cells were detected in the GCs of the DEL-immunized mice
(Fig. 2c). The inability to detect DEL-binding B cells may be
due to the sensitivity of the immunochemical system employed.
We have established a system in which affinity maturation of a
trackable population of antigen-specific B cells can be analysed
during the germinal centre reaction in vivo.
Somatic hypermutation in germinal centres responding to
DEL and HEL
The Vk and VH region transgenes were amplified by nested
PCR from 12 IgMaþ, PNAþ GCs at various stages of the
primary response to both HEL-cOVA and DEL-cOVA. The
GCs were identified by PNA staining and consisted of approxi-
mately 400–600 cells. Care was taken to avoid the inclusion of
PNA negative/non-transgenic B cells in the surrounding area.
The average mutation rate in the germinal centres for both
the HEL-cOVA and DEL-cOVA immunized mice was fairly
similar, ranging from 03 to 05% (Table 2).
There was extensive variability in the mutation rate between
germinal centres with the occasional GC displaying no muta-
tions within the sample of transgenes analysed. This supports
previous findings that substantial clonal expansion within germ-
inal centres can occur without activation of the hypermutation
mechanism,42,43 although other reports have suggested that
ongoing mutation may occur in all GCs.44,45 Inactivation of
the hypermutation machinery may be advantageous at the early
stages of germinal centre formation since the accumulation of
deleterious mutations within the GC founder cells would be
detrimental.
Intrinsic mutational hotspots encoded by an RGYW motif
(R ¼ A or G, Y ¼ C or T, W ¼ A or T)8,14 were observed
within the VH and Vk region transgenes of GCs from HEL-
cOVA and DEL-cOVA immunized recipients (Fig. 3). Muta-
tions at these hotspots tend to produce conservative coding
changes such as serine to asparagine/threonine, hence preser-
ving antibody structure. Additionally, the somatic hypermuta-
tion machinery displays a strong bias of transitions over
transversions (59% compared with the 33% anticipated on a
random bias);8 60% of the mutations were transitions in this
experimental system. These results indicate that somatic hyper-
mutation of the antigen-specific B cells was occuring in a
primary immune response to a protein antigen in vivo.
Clonal proliferation within GCs
Reconstruction of the hypermutation and clonal expansion
events that took place in each GC was undertaken using a
previously established procedure for building genealogical
dendrograms (Fig. 4).42,44
Potentially affinity-enhancing mutations were retained
through a number of cell divisions in some B cell clones
(Fig. 4a,b). This may reflect a situation where B cells with
antigen-enhancing mutations are being selected and recirculat-
ing for additional rounds of somatic mutation (branching
dendrograms). Many GCs at days 9 and 14 from the HEL-
cOVA and DEL-cOVA immunized recipients displayed muta-
tionally distinct B cells emanating from the unmutated trans-
genes. These dendrograms are described as simple (Fig. 4c)
where a number of B cells containing one or two mutations but
no shared mutations were observed. These simple dendrograms
suggest that there is an ongoing emigration of B cells leaving
the GC without further rounds of division and mutation. The
fact that the transgenic B cells already have moderate aff-
inity for DEL and high affinity for HEL may explain this
observation.
Figure 1. Kinetics of D01110 Tand MD4 B cell clonal expansion after
immunization. Cell suspensions containing 1–5  106 CD4þKJ126þ T
cells and B220þ HELþ B cells were transferred into BALB/c-
Ighb  C57BL/6 F1 mice. On day 0, transferred recipients were injected
s.c. with either 130 mg of HEL-cOVA or DEL-cOVA in CFA. The
percentage of (a) D01110 (CD4þKJ126þ) T cells and (b) MD4
(B220þIgMaþ) B cells in the lymph nodes of adoptively transferred
recipients were determined by flow cytometry at days 3, 5, 7, 9 and 14
after immunization. Each time-point represents the mean  range for at
least two mice per group. Unimmunized controls from each time-point
were averaged and represented as day 0.
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Figure 2. Immunohistochemical analysis of GCs in lymph nodes of HEL-cOVA and DEL-cOVA immunized mice. The consecutive
sections were stained with either anti-Thy12 (brown) or peanut agglutinin (PNA) and either anti-IgMa, HEL or DEL (blue).
Magnification was at  100. (a) Germinal centre from a HEL-cOVA immunized mouse, d9, IgMaþ Thy12þ (left) and HELþPNAþ
(right). (b) Germinal centre from a DEL-cOVA immunized mouse, d9, IgMaþThy12þ (left) and HELþPNAþ (right). (c) Germinal
centre from a DEL-cOVA immunized mouse, d9, DEL PNAþ.
# 2003 Blackwell Publishing Ltd, Immunology, 108, 274–287
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Neighbouring GCs from the same section of lymph node
were also examined in two cases and no sequences with shared
mutations were observed (unpublished data). This is in agree-
ment with previous work suggesting that little or no inter-GC B
cell migration takes place and that somatic hypermutation
occurs completely independently in individual GCs.45,46
Affinity maturation towards DEL
Changes in the relative affinity of the HyHEL-10 antibody for
DEL and HEL were measured by competitive inhibition. Sera
from adoptively transferred recipients immunized with either
HEL-cOVA or DEL-cOVA were analysed at days 9 and 14.
HyHEL-10 antibodies in the sera of DEL-immunized mice
consistently showed increased affinity for DEL, both in solution
(Fig. 5a) and in solid phase (Fig. 5b), compared with sera from
HEL-immunized mice. A unique population of DEL-specific Tg
antibodies, which could not be inhibited at high concentrations
of HEL, was detected in the sera of DEL-cOVA immunized
mice (Fig. 5b). These results provide evidence that somatic
hypermutation within the Vkand VH region transgenes resulted
in increasing affinity for DEL in response to immunization with
DEL-cOVA.
Protein modelling of the affinity maturation process
High-resolution structural characterization of the HyHEL-10/
HEL interaction27–29 has allowed the examination of individual
replacement mutations that have occurred within this experi-
mental system. Crystallography studies have identified 14
hydrogen bonds, 111 Van der Waals contacts and one salt bridge
within the interface of the HyHEL-10/HEL complex.28 The
shape of the antigen-binding site is a very shallow concavity
consisting of acidic and non-hydrophobic residues, bordered by
hydrophobic segments.27 There are 21 differences between the
amino acid sequence of HEL and DEL (at positions 3, 4, 15, 33,
34, 37, 57, 68, 73, 75, 77, 82, 85, 90, 91, 92, 93, 97,116, 121,
122; 22 in Duck form III),25 and these amino acids changes were
modelled using the SwissPdb viewer version 33b3.
Of the 21 differences between HEL and DEL, six (in bold
type, above) lie at the antigen–antibody interface, by inference
from the HyHEL-10/HEL structure. All six occur in one half of
the antibody interface: CDR2(L), CDR1(H) plus CDR3(H) and
not CDR2(H), CDR1(L) or CDR3(L). This is illustrated in
Fig. 6g.
This leads to an enquiry as to whether any of these six
residues are near to any of the antibody residues that mutate
during the affinity maturation process in vivo. The answer is one
of them, namely residue 93. In HEL, residue 93 is an asparagine
whose side chain is specifically hydrogen-bonded to the side
chain of the 53Vk glutamine, as seen in Fig. 6a. In DEL, residue
93 is an arginine, with a side chain of different hydrogen bond
specificity.
Nearby, a striking feature of the antigen-binding site in the
HyHEL-10/HEL complex is the 49Vk lysine, which is promi-
nently exposed and accessible at the centre.27 This residue was
Table 2. Summary of sequencing results obtained from individual GCs at different days after immunization with DEL-cOVA or HEL-cOVA
GC Day V gene
Description
of B-cell clones
No. of unique
sequences
No. of
mutations
% unmutated
transgenes
A. DEL-cOVA immunized mice
B 5 H Simple 5 6 636 (7/11)*
D 5
L Branching 5 7 555 (5/9)
H Simple 3 2 818 (9/11)
A 9 L Simple 4 5 429 (3/7)
H 9
L Branching 4 7 20 (1/5)
H Extensive branching 9 13 333 (3/9)
J 9 H Simple 4 5 0 (0/7)
L 9 H No SMy 1 0 100 (6/6)
A 14
L Extensive
Branching
7 14 385 (5/13)
H No SM 1 0 100 (11/11)
B. HEL-cOVA immunized mice
C 9
L Branching 11 15 412 (7/17)*
H Branching 9 18 438 (7/16)
F 9 L Simple 4 6 30 (3/10)
G 9 L Simple 7 6 40 (4/10)
D 14 H Simple 4 4 70 (7/10)
K 14 L Simple 4 3 40 (4/10)
(A) Average VL mutation rate ¼ 049%; average VH mutation rate ¼ 032%. (B) Average VL rate ¼ 036%; average VH rate ¼ 05%.
Results obtained from the analysis of primary GCs over days 5, 9, and 14. Data from individual GCs are shown on separate lines. The number of unique somatic
mutations per GC was evaluated by counting mutations shared by two or more VH/VL clones only once. Average mutation frequency per V-gene base pair was
calculated by dividing total number of somatic mutations observed by the total number of base pairs sequenced. Dendrograms containing a number of mutationally
distinct B cells emanating from the unmutated transgene were described as simple. A branching dendrogram represents a number of B cells with shared and unique
mutations, which can be followed along one arm of the dendrogram.
*The number of unmutated transgenes in the total number of sequences analysed is shown in parentheses.
yNo SM ¼ no mutations were observed.
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Figure 3. Representative examples of the Vkand VH sequence data obtained from GCs at various stages of the HEL-cOVA/DEL-cOVA response. Each sequence is compared to the relevant
HyHEL-10 transgene: (a) Vk; (b) VH. Sequences of CDR1/CDR2 and CDR3 are completely shown as well as the flanking sections where somatic mutation was observed. Identity with the
transgene is indicated by a dash and nucleotide differences are shown. The number of days after immunization and the antigen used are indicated in the left hand column. Numbers in front of
the sequence alignment are arbitrary sequence names and the letter depicts the different isolated germinal centres. The CDRs in this figure are labelled according to Lavoie et al. 199934 and the
amino acids in bold represent contact residues.
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seen to mutate independently in GC B cells to an asparagine or a
methionine at days 9 and 14, respectively (Fig. 3a). The func-
tional importance of these somatic mutations at residue 49Vk
was indicated by modelling of the HyHEL-10/DEL interface
(Fig. 6b,c). The asparagine produced by point mutation at
residue 49Vk interacts directly, via hydrogen-bonding, with
the DEL-specific amino acid, arginine 93 mentioned above. The
methionine at 49Vkmay also result in enhanced binding to DEL
through donation of electrons by the sulphur of the methionine
to the guanidino group of arginine 93 (Fig. 6c). The importance
of this position for antigen binding has been demonstrated by
site-directed mutagenesis studies in which conversion of the
lysine at residue 49Vk to a threonine increased the affinity of the
HyHEL-10 antibody for duck egg lysozyme approximately
fivefold.25 It is remarkable that the predicted importance of
mutations at this position has been confirmed in an antigen-
specific B cell response in vivo.
At the rest of the antibody–antigen interface where residue
changes between HEL and DEL are not seen, some k chain
mutations were found in GC B cells. The serine to asparagine
replacement mutation at position 93Vk in CDR3 (Fig. 3a), also
previously examined by site-directed mutagenesis, does not sig-
nificantly alter affinity for DEL, at least in the presence of thre-
onineat residue49Vk.25 Proteinmodellingof thismutation,which
is next to a contact residue, displays no alteration in hydrogen
bonding within the Ag–Ab interface. Thr/Asn/Asp/Ser amino
acids often occur in similar hydrogen bonding arrangements
and, in such situations, can be considered interconvertible.47,48
Serine 91Vkof the light chain, which is a contact residue in
CDR3 with the HEL and DEL amino acid tyrosine 20, is
believed to be a mutational hotspot. Conserved coding changes
from serine 91Vk to asparagine or threonine were observed at
days 5, 9 and 14 in DEL-cOVA responding GCs only (Fig. 3a)
and modelling suggests the possibility of maintenance of inter-
actions with Tyr20. The Vk transgenes from DEL-cOVA immu-
nized mice showed a very high preference for transition
replacements, particularly in CDR3, which may reflect the
requirement for modification to increase interactions with the
lower affinity antigen, DEL. This is surprising, because most of
the non-identical DEL residues at the Ag–Ab interface are
interacting with CDR2(L) and HEL/DEL residues close to
CDR3(L) are identical.
Mutations in the framework regions, notably at serine
residues 74Vk and 77Vk in the light chain of monoclonal
antibody, HyHEL-8, were also observed in this experimental
system. These are considered to be intrinsic hotspots within the
light chain nucleotide sequence with conservative coding
changes that preserve the antibody structure and are unlikely
to affect antigen/antibody interactions.
Overall, the variable heavy chain transgene displayed a
lower level of mutation compared with the light chain, with
no mutations shared between independent GCs from the HEL-
cOVA and DEL-cOVA GCs (Fig. 3b). Protein modelling of the
mutation of the CDR2 contact residue serine 56VH to aspar-
agine, which was observed at day 9 in a DEL-cOVA GC, showed
an enhanced hydrogen-bond interaction with the lysozyme
amino acid, aspartic acid 101, which is present in both the
HEL and DEL. This mutation also occurs within the HyHEL-8
antibody, which displays higher affinity for DEL.25
Figure 4. Clonal proliferation of B cells within individual GCs. A
simplified hypothesis that each V-gene containing a unique set of
mutations represents a distinct GC B cell was made. Each branch of
the dendrogram represents mutations that were shared by several V-
genes, using the assumption that the mutation event occurred only once
in a precursor cell and was inherited by daughter cells. Numbers on
branches represent the number of mutations (silent mutations are
enclosed in brackets) between the different sequences. Each circle
symbolizes a B cell and letters within the circles depict individual
sequences. Branching dendrograms represent VH (a) and Vk (b)
sequences derived from independent GCs from days 9 and 14, respec-
tively, in the DEL-cOVA response. The VH antigen-selected hotspot
Ser56!Asn is symbolized by B cells, I, J and K on the right-hand side of
the dendrogram (a). The ‘affinity-enhancing’ mutation Lys49!Met of
VL is depicted by letters E, F, G and H on the left-hand side of the
dendrogram (b), and B cell, H, also contains the intrinsic hotspots,
Ser77!Ile and Ser91!Asn. (c) depicts a simple dendrogram produced
from the Vk sequence data from a HEL-cOVA GC.
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Protein modelling of the other coding changes within and
around the CDRs typically displayed conserved mutations,
which are unlikely to have a major impact on antigen/antibody
interaction. As no recurring mutations were observed we cannot
rule out the possibility that some of these individual mutations
may have resulted from PCR error.
Significantly, no coding changes were detected at the heavy
chain residue, aspartic acid 32VH that is essential for main-
taining the salt bridge to lysine/arginine 97 at the HEL and DEL
interface, respectively. Additionally, little mutation was
observed in the lower portion of the antigen binding site that
is dominated by a cluster of tyrosine residues over the L3 and
H2 areas. These Tyr amino acids are believed to create more
favourable Ag–Ab interactions through their clustering effec-
tively preventing contact of any other surrounding residues from
direct interaction with HEL.27,49
Comparison of patterns of somatic mutation between HEL
and DEL-cOVA immunized mice
Comparison of the total sequence data from GCs of mice
immunized with DEL-cOVA and HEL-cOVA revealed different
patterns of replacement mutations. Coding changes such as the
mutations at 49Vk, which increase binding to DEL, were not
detected in GCs responding to HEL. Since most of the unshared
DEL residues were in the vicinity of CDR2(L), CDR3(H) and
CDR1(H), one might predict a larger number of affinity-enhan-
cing mutations in that half of the antibody interface. This was
not observed, possibly because any bias would be small due to
sample size.
Three light chain mutations were repeated in distinct GCs
responding to HEL and DEL. It is unlikely that these mutations
could have occurred at random and therefore are likely to have
been selected during the GC response. Protein modelling indi-
cated that two of the residues at these sites, IIe29 and Gln90, are
essential for the conservation of the structure of the canonical
loops.50,51 According to the canonical class alignment defini-
tions, residue 29 is allowed to be a Val or a Ile, to maintain the
class 2 L1 loop and the amino acid at position 90 must be either
a Gln, Asn or a His amino acid to preserve the class 1 L3 loop
structure.52 Modelling of the mutations (IIeVk29!Phe and
GlnVk90!Arg) indicated that they were energetically unfa-
vourable, and were likely to make a structural change in the
loop. These canonically important residues were observed to
mutate simultaneously with other local amino acids in the same
CDR (IleVk29!Phe with AsnVk32!Ser, GlnVk90!Arg
with SerVk93!Ile), suggesting that, the local mutations
observed in CDRL1 and CDRL3 could be compensating for
Figure 5. Relative affinity of IgMa transgenic antibodies in sera from HEL-cOVA and DEL-cOVA immunised recipients at days 9 and
14, by competitive ELISA. (a) Competitive binding of IgMa antibodies to HEL (solid phase) by DEL (soluble phase); (b) competitive
inhibition of IgMa antibodies to DEL (solid phase) by HEL (soluble phase); average of two identical experiments.
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the rearrangement of the CDR loop caused by the mutation of
these canonical important residues.
Endogenous germline genes
Because the primers were specific for the Vk23 and VH36-60
gene families, a few rearranged germline Vkand VH genes were
also cloned from some of the IgMaþ, PNAþ GCs. More
endogenous Vk23 and VH36-60 genes were cloned from the
GCs of DEL-cOVA recipients (35%) than from HEL-cOVA
immunized animals (3%), which probably reflects competition
between the transgenic and endogenous B cells for the lower
affinity antigen, DEL. The number of mutations in these
endogenous V genes was similar to the number of mutations
observed in the transgenic light chains. An endogenous VH-
gene (with different D and J regions), that was a constituent of
a polyreactive antihistone IgM antibody (GenBank accession
no: X63801), was independently cloned at days 9 and 14 from
DEL-cOVA immunized mice. This VH region is not a docu-
mented germline gene11 and has been shown previously to bind
HEL.53
DISCUSSION
In this study, we have demonstrated affinity maturation of
germinal centre B cells responding to two defined protein
Figure 6. Protein modelling of antibody–lysozyme interactions. (a) Area of the antigen-binding site showing details of the interactions
between HEL and the mouse HyHEL-10 anti-HEL antibody, based on the crystal structure of the Fab–antigen complex.28 (b) Model of
the same region showing the effects of the LysVk49!Asn mutation on the interaction between the maturation mutant antibody and
DEL. (c) Model of the same region showing the effects of the LysVk49!Met mutation on the interaction with DEL. (d–g) Views of the
HyHEL-10 antigen-binding site seen perpendicularly to the antibody–antigen interface. (d) employs the colour scheme of (f) and shows
the position of the interacting side chains of residues LysVk49 (red) and the HEL Asn93 (superimposed in black). (e) The two V
domains: VH in green and Vk in blue. (f) As (e) with the positions of the CDR regions shown by different colours. Vk: CDR1, pale blue;
CDR2, grass green; CDR3, violet. VH: CDR1, white; CDR2, orange; CDR3, yellow. (g) The same as (f) except that the side chains of
the six interface residues differing between HEL and DEL are superimposed in black. Their size is reduced in (d) and (g) for clarity and
the residue number is indicated at the right-hand side.
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antigens at the cellular and molecular level directly in vivo using
a novel adoptive transfer model. This in vivo system exploits
the different affinities of the HyHEL-10 antigen receptor for
the monomeric protein antigens, hen egg lysozyme (Ka ¼
45  1010 M1) and duck egg lysozyme (Ka ¼ 13  107
M
1) and the fact that their conjugation to chicken ovalbumin
allows provision of T cell help by cOVA-specific D01110 T
cells.20,21 Previous in vitro and in vivo studies have examined
various individual components (clonal expansion, GC forma-
tion, affinity maturation) of the antibody response but to our
knowledge no sequential detailed analysis of the overall process
to a protein antigen has been performed. This system has
allowed us to track, in detail, at the level of antigen-specific
B cells in vivo, all of these molecular and cellular events that
occur during the development of an antibody response in one
integrated experimental system. Not only will this have impli-
cations for a variety of therapeutic approaches, but it also
provides an ideal system for studying the mechanisms under-
lying somatic hypermutation in vivo.
To ensure that DEL coupled to cOVA can elicit B cell help
from TCR Tg T cells, as reported previously for HEL, we
examined the clonal expansion of Tg T and B cells. Tg T cells
responded more slowly to immunization with DEL-cOVA than
with the higher affinity antigen (HEL-cOVA). This slower T cell
response could be due to the low affinity of the BCR for DEL,
resulting in less efficient presentation to T cells and hence
slower recruitment of T cell help.40 Alternatively, the lower
affinity of the BCR for DEL may lead to competition for antigen
between B cells and other antigen-presenting cells such as
dendritic cells for presentation to T cells. Comparison of the
levels of endogenous anti-cOVA IgG1 and IgG2a produced in
response to HEL and DEL-cOVA indicates that the latter
interpretation may be correct (unpublished data). Previous in
vitro work has shown that, as the affinity of the BCR increases,
there is a corresponding diminution in the amount of soluble
antigen required to trigger a response, until the ability to dis-
criminate further increases in affinity disappears above 1010
M.54–56 Our study demonstrates for the first time that discrimi-
nation between a moderate (Ka ¼ 107 M1) and a high-affinity
(Ka ¼ 5  1010 M1) antigen also occurs during antigen pre-
sentation in vivo.
As we demonstrated that T and B cell clonal expansion
occurs with HEL-cOVA and DEL-cOVA we were next able to
employ the system to examine somatic hypermutation. To date,
somatic hypermutation has been investigated only in GCs
responding to haptens, due to the complexity and heterogeneity
of the immune response to protein antigens. Many more con-
tacts occur at the Ab–protein interface, which covers a much
larger area, hence the process of antigenic-selection may be very
different during the response to a protein antigen compared with
the anti-hapten response.
The overall mutation rate within the GCs of this adoptive
transfer system was fairly low (04%) but was significantly
higher than the PCR error rate (008%),57 and comparable with
mutation rates from other primary responses.45,58 Characteris-
tics associated with somatic hypermutation such as a bias
towards transitions and intrinsic hotspots, were also observed
in the B cell transgenes. These results confirm the findings of
other workers,39 who have also shown somatic hypermutation in
the HyHEL-10 Vk transgene in Peyer’s patches of intact MD4
mice. However, in this case the antigen driving the response was
unclear.
Possible reasons why the mutation rate is low in the system
we describe are numerous. First, the heavy and light chain
transgene cassettes are present in multiple copies and cointe-
grated into the genome, but not at the endogenous Igh and Igk
loci, in the MD4 transgenic mouse strain.23 Each Tg cassette
contains a strong Ig promoter and the intronic enhancer, which
are essential elements for the initiation of somatic hypermuta-
tion.59–61 This study and previous work verify that the correct
placement of the transgenes within the Ig locus is not critical for
mutation.39,62–64 However, the Ig heavy chain 30 enhancer
downstream from the Cm region is not present. Prior work
has indicated that the lack of a 30 heavy chain enhancer reduces
the rate of somatic hypermutation,65,66 which could explain the
lower mutation rate observed in the heavy chain transgene
compared with the k transgene in which the 30 enhancer is
present. Additionally, the Vk and VH HyHEL-10 transgenes
contain two and 13 nucleotide differences from the nearest
germline genes, Vk23 and VH36-60, respectively.34 Some of
these are in mutational hotspots, which are therefore no longer
available for targeting. Finally, the HyHEL-10 BCR displays a
moderate affinity for DEL, hence the low accumulation of
mutations could be explained by ongoing emigration of Tg B
cells without the requirement for recycling, since they can
receive adequate survival signals through the BCR. Some
GCs contain many B cells that have acquired one or two unique
mutations only, indicating that they do not contain numerous
recycling B cells. Additionally, other experimental systems may
be observing memory B cells, recycling through germinal
centres for further rounds of mutation. The transgenic B cells
are unable to develop into memory cells due to the absence of
switch recombination sites.67
Having demonstrated somatic hypermutation, we next det-
ermined whether the changes observed would be predicted to
lead to an increase in affinity for the antigens in question.
Competitive inhibition studies demonstrated an increase in
affinity of serum antibodies, produced by transgenic B cells,
towards DEL in DEL-cOVA immunized mice. Strong evidence
for selection of mutations that shift the affinity from HEL to
DEL is provided by the systematic detection of the light chain
framework region mutations, 49Vk (Lysine! Methionine/
Asparagine) in different DEL-cOVA recipients. The CDRs of
HyHEL-10 are very short and 49Vk is adjacent to the CDRL2,
such that lysine 49 is in the centre of the DEL/HyHEL-10
interface. Protein modelling and previous site-directed muta-
genesis experiments demonstrate that these mutations enhance
affinity for DEL. Light chain mutations, Lys49Vk!Thr and
Ser93Vk!Asn, were targeted by site-directed mutagenesis25
due to the observation that HyHEL-10 and HyHEL-8 mono-
clonal antibodies, which share the same heavy and light chain
V-genes (Vk23, VH36-60), differed in their ability to bind
lysozymes from several species of birds, due to the positions of
their somatically mutated amino acid residues.68 Four of the
five somatically mutated amino acid residues which differ
between the HH8 and HH10 light chains (Vk residues 49,
74, 77, 93),34 were present within DEL-cOVA GC B cells and
these have been shown to increase affinity for DEL sevenfold
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by chain recombination experiments.25 The intrinsic Vk muta-
tional hotspots Ser74 and 77 may have a subtle effect on
affinity, although they are distant from the antigen-binding
site. Although protein modelling can suggest local changes
in antibody structure, it is unable to predict co-operative
alterations in structure between somatically mutated residues
or long range effects.69,70 Protein modelling of numerous other
replacement mutations in the light chain did not reveal direct
interactions with DEL. Most coding changes appeared to be
neutral, conserving antibody–antigen interactions and antibody
structure. Mutations that are neutral in terms of affinity may
offer selective advantages towards secretion, folding and phy-
sical stability.71
The observation that the canonically important light chain
residues, IIe29 and Gln90,50,51 were independently mutated
to Phe and Arg, respectively, in the HEL-cOVA and DEL-
cOVA suggests the influence of selective pressure, although
we do not have direct evidence for an effect on antigen
binding.
Replacement mutations in GC B cells responding to HEL-
cOVA did not appear to be selected as none were repeated
independently. The affinity of HyHEL-10 for HEL (45  1010
M
1) is believed to be near the effective ceiling for antibodies as
B cells expressing very high affinity receptors do not show a
significant advantage over this threshold as measured by com-
petition for antigen bound to FDCs72 or improved antigen
presentation to T cells.54 Roost et al.73 demonstrated that
germline genes encoding antibodies with high affinity for
vesicular stomatitis virus showed no affinity maturation over
the course of the immune response. Recently, it has been shown
that antibody fragments with femtomolar affinities can be
evolved by mutagenesis in vitro, demonstrating that limitations
imposed by the antibody architecture are not intrinsically
responsible for the affinity ceiling.74 Importantly, our data show
that B cells expressing antigen-receptors close to their affinity
threshold are capable of revising their specificity by somatic
hypermutation and selection in response to a low-affinity, cross-
reactive antigen. This capability would allow further repertoire
development of high affinity memory B cells, which could be
important during the immune response to a pathogen under-
going antigenic drift. However, this advantage is offset by the
danger that a similar repertoire shift could result in switching
from an anti-pathogen response towards a low-affinity, cross-
reactive autoantigen (antigen mimicry). Remarkably, mutations
in this in vivo system recur independently at identical residues
indicating that the affinity maturation process within the
immune response is extremely selective. The effects of indivi-
dual point mutations on the affinity of the transgenic HyHEL-10
antibody towards HEL and DEL are currently being investi-
gated using scFv antibody fragments and surface plasmon
resonance.
To our knowledge, this is the first time that affinity matura-
tion of the GC response to high and low affinity cross-reactive
protein antigens has been followed through completely from the
clonal expansion of B and T cells in germinal centres to the
effects of somatic mutations on the interaction of the antigen-
binding site with its epitope. This model also provides an ideal
system for studying the mechanisms underlying somatic hyper-
mutation in vivo.
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